Potentiation of the tumor cytotoxicity of melphalan by vasodilating drugs
Authors:
- 31 May 1989
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 16 (5) , 1131-1135
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gainInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1987
- Potentiation of RSU-1069 tumour cytotoxicity by 5-hydroxytryptamine (5-HT)British Journal of Cancer, 1986
- Selective drug-induced reduction of blood flow in tumor transplantsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1985
- 31P nuclear magnetic resonance evidence for the regulation of intracellular pH by Ehrlich ascites tumor cells.Journal of Cell Biology, 1982
- A soft agar colony assay for Lewis lung tumour and B16 melanoma taken directly from the mouseBritish Journal of Cancer, 1976
- Blood flow and oxygenation of tumors in mice.II. Effects of vasodilator drugsCancer, 1967
- The effect of glucose pretreatment on the carcinostatic and toxic activities of some alkylating agentsBiochemical Pharmacology, 1964
- Potentiation of 5-Fluorouracil Inhibition of Flexner-Jobling Carcinoma by GlucoseScience, 1963
- Changes of Oxygen Tension in Tumours Induced by Vasoconstrictor and Vasodilator DrugsActa Radiologica, 1962
- Increased sensitivity of the Walker tumour towards aromatic nitrogen mustards carrying basic side chains following glucose pretreatmentBiochemical Pharmacology, 1961